At NAMSA, we understand that the process of bringing innovative ophthalmic medical devices to market can be a time-consuming and difficult process. The need for absolute certainty in the capabilities of your contract research organization (CRO) partner is vital.
NAMSA’s comprehensive offering of toxicological (in vitro and in vivo), analytical chemistry, microbiology testing services, regulatory and clinical trial support provide our clients all the global reach and service they need, while working with one single source.
Whether you’re developing contact lenses, intraocular lenses, solutions or drug delivery devices, our industry leading expertise and experience will show you the ultimate path to market. Our Technical Specialists and Scientists are adept at developing non-clinical and clinical testing programs for these devices and other ocular products with proven methods based on international requirements.
Areas where NAMSA has experience:
- Corneal healing studies
- Intraocular lens studies (ISO standard)
- Vitreal procedures and replacement materials
- Conjunctival implants
- Aqueous shunts
- Ocular pathology consultation
- Histopathology of device in situ
- Glaucoma implants
- Contact Lenses
- Contact Lens Containers
- Intraocular Lens Container
- Drug Delivery Devices
- Topical Therapies and Solutions
Intraocular Implant Studies
- Retinal implants
- Contact lens solutions
- Irrigation fluids